Published in Br J Pharmacol on March 01, 2006
TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron (2008) 2.94
Cytotoxic edema: mechanisms of pathological cell swelling. Neurosurg Focus (2007) 1.41
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc Res (2009) 1.38
Psychiatric Disorders and TRP Channels: Focus on Psychotropic Drugs. Curr Neuropharmacol (2015) 1.11
Non-selective cation channels, transient receptor potential channels and ischemic stroke. Biochim Biophys Acta (2007) 1.03
Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol Sci (2008) 1.01
Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats. Br J Pharmacol (2007) 1.00
TRPV1: a stress response protein in the central nervous system. Am J Neurodegener Dis (2012) 0.98
Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Transl Stroke Res (2013) 0.96
Role of cannabinoids and endocannabinoids in cerebral ischemia. Curr Pharm Des (2008) 0.92
Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity. Neural Plast (2016) 0.86
Update on the role of cannabinoid receptors after ischemic stroke. Mediators Inflamm (2012) 0.85
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands. Br J Pharmacol (2006) 0.82
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms. Mol Pain (2015) 0.81
Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors. Br J Pharmacol (2007) 0.78
The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα. Mol Pharmacol (2012) 0.77
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. PLoS One (2014) 0.75
The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron (1998) 13.03
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 10.05
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett (1994) 5.30
Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther (1997) 5.20
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A (2000) 2.87
Selective vulnerability of the hippocampus in brain ischemia. Neuroscience (1991) 2.18
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem (2001) 2.13
In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther (1996) 1.85
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology (2002) 1.75
The effects of 5-minute ischemia in Mongolian gerbils: I. Blood-brain barrier, cerebral blood flow, and local cerebral glucose utilization changes. Acta Neuropathol (1983) 1.60
Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol (1999) 1.50
Biphasic effects of anandamide. Pharmacol Biochem Behav (1998) 1.41
Brain lesions that produce delta waves in the EEG. Neurology (1977) 1.37
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J (2001) 1.29
Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol (2002) 1.29
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J Neurochem (2004) 1.24
Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A. Neuropsychopharmacology (2001) 1.18
Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J Neurosci (2003) 1.15
To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents? Trends Pharmacol Sci (1998) 1.14
Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.13
Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell Mol Life Sci (2003) 1.12
CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther (1998) 1.12
Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J Neurosci (2005) 1.10
Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol (2004) 1.09
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur J Pharmacol (1997) 1.07
Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem J (2001) 1.06
Cannabinoid modulation of intestinal propulsion in mice. Eur J Pharmacol (1998) 1.05
Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci (1996) 1.03
Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol Sci (1995) 1.02
Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur J Pharmacol (1995) 1.00
Experimental brain infarcts in cats. I. Pathophysiological observations. Stroke (1981) 0.98
Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. J Neural Transm (Vienna) (2000) 0.98
Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils. Neurosci Lett (2003) 0.92
Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur J Neurosci (2003) 0.92
Capsaicin exhibits neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils. Br J Pharmacol (2005) 0.92
Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover. Pharmacol Biochem Behav (2003) 0.91
Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h). J Neurosci (2003) 0.91
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. Eur J Pharmacol (2002) 0.89
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J Pharmacol Exp Ther (1998) 0.88
Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity. J Neurochem (2002) 0.87
Behavioral, electroencephalographic and histopathological studies on mongolian gerbils with occluded common carotid arteries. Physiol Behav (1986) 0.86
Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementarmed (1999) 0.85
The characterization of an amnesic syndrome following hypoxic ischemic injury. Arch Neurol (1983) 0.83
CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils. Neurosci Lett (2000) 0.82
Ischemia-induced irreversible deficit of memory function in gerbils. Brain Res (1992) 0.81
Effect of idebenone (CV-2619) on memory impairment observed in passive avoidance task in rats with cerebral embolization. Jpn J Pharmacol (1985) 0.80
Quantitative analysis of the electrocorticogram after forebrain ischemia in the rat. Pharmacology (1995) 0.79
Differentiation between cortical and subcortical lesions following focal ischemia in cats by multimodality evoked potentials. J Neurol Sci (1987) 0.78
Short-term memory and cerebral ischemia: pharmacological application. Eur Neurol (1981) 0.78
Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil. Eur J Pharmacol (1997) 0.78
Neurotolerability of contrast agents in rats with brain ischemia induced by transient middle cerebral artery occlusion: EEG evaluation. Invest Radiol (2001) 0.77
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development (2004) 3.75
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry (2011) 2.25
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology (2008) 1.44
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus (2009) 1.40
Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behav Brain Res (2004) 1.10
Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol (2004) 1.09
Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward. Biol Psychiatry (2007) 1.09
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol (2009) 1.07
SNAP-25 in neuropsychiatric disorders. Ann N Y Acad Sci (2009) 1.05
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology (Berl) (2007) 1.04
Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats. Neuropsychopharmacology (2007) 1.00
Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils. Neurosci Lett (2003) 0.92
Capsaicin exhibits neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils. Br J Pharmacol (2005) 0.92
5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. Eur J Pharmacol (2006) 0.90
Epileptiform activity and cognitive deficits in SNAP-25(+/-) mice are normalized by antiepileptic drugs. Cereb Cortex (2012) 0.89
Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity. EMBO J (2013) 0.89
Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish. Psychopharmacology (Berl) (2011) 0.88
Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis. Hum Mol Genet (2009) 0.86
Role of the endocannabinoid system in MDMA intracerebral self-administration in rats. Br J Pharmacol (2002) 0.85
3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats. Behav Neurosci (2002) 0.84
Neuroprotective effects of genistein in Mongolian gerbils: estrogen receptor-β involvement. J Pharmacol Sci (2010) 0.83
Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction. Pharmacol Biochem Behav (2005) 0.81
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation. Br J Pharmacol (2013) 0.81
Mice discriminate between stationary and moving 2D shapes: application to the object recognition task to increase attention. Behav Brain Res (2013) 0.79
Effects of clioquinol on memory impairment and the neurochemical modifications induced by scrapie infection in golden hamsters. Brain Res (2009) 0.78
Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish. Psychopharmacology (Berl) (2013) 0.77
Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats. Int J Toxicol (2011) 0.77
Pharmacokinetics and distribution of clioquinol in golden hamsters. J Pharm Pharmacol (2007) 0.76
Diazepam protects against the enhanced toxicity of cocaine adulterated with atropine. J Pharmacol Sci (2008) 0.76
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors. Psychopharmacology (Berl) (2014) 0.76
Neurohypophyseal hormones protect against pentylenetetrazole-induced seizures in zebrafish: role of oxytocin-like and V1a-like receptor. Peptides (2012) 0.75
Cytoarchitectural, behavioural and neurophysiological dysfunctions in the BCNU-treated rat model of cortical dysplasia. Eur J Neurosci (2012) 0.75